CIALIS - AN OVERVIEW

In Oct 2007, the FDA declared the labeling for all PDE5 inhibitors, including tadalafil, needs a extra well known warning of the possible risk of unexpected hearing decline as the results of put up-advertising and marketing stories of non permanent deafness associated with usage of PDE5 inhibitors.[19]El tadalafilo puede causar efectos secundarios.